Clinical trial
Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
NCT02839915 is registered in ClinicalTrials.gov with Southwest Autism Research & Resource Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
- Lead sponsor
- Southwest Autism Research & Resource Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 13, 2020
- Completion date
- July 31, 2026
- Enrollment
- 56 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.